Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 26, 2017

DrugPatentWatch Database Preview

Cefuroxime sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cefuroxime sodium and what is the scope of patent protection?

Cefuroxime sodium
is the generic ingredient in seven branded drugs marketed by Fresenius Kabi Usa, Hospira Inc, Facta Farma, Watson Labs Inc, Igi Labs Inc, Hikma Farmaceutica, Samson Medcl, B Braun, Lilly, Teva Pharms, and Acs Dobfar, and is included in twenty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixty-one drug master file entries for cefuroxime sodium. Six suppliers are listed for this compound.

Summary for Generic Name: cefuroxime sodium

Drug Master File Entries: see list61
Suppliers / Packagers: see list6
Bulk Api Vendors: see list48
Clinical Trials: see list929
Patent Applications: see list972
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cefuroxime sodium at DailyMed

Pharmacology for Ingredient: cefuroxime sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun
cefuroxime sodium
INJECTABLE;INJECTION050780-001Feb 21, 2001APRXYesYes► Subscribe► Subscribe
Igi Labs Inc
cefuroxime sodium
INJECTABLE;INJECTION050558-003Oct 19, 1983APRXYesYes► Subscribe► Subscribe
Hikma Farmaceutica
cefuroxime sodium
INJECTABLE;INJECTION065046-001Jan 9, 2004APRXNoNo► Subscribe► Subscribe
Facta Farma
cefuroxime sodium
INJECTABLE;INJECTION064124-001May 30, 1997APRXNoNo► Subscribe► Subscribe
cefuroxime sodium
INJECTABLE;INJECTION062592-002Jan 10, 1986DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus